PACIRA BIOSCIENCES, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PACIRA BIOSCIENCES, INC. (PCRX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$103.32 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2019-08-08
- PACIRA BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-06-30 was -$181.80M, a 405.17% decline year-over-year.
- PACIRA BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-03-31 was $78.48M.
- PACIRA BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-12-31 was -$123.16M, a 1515.83% decline year-over-year.
- PACIRA BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-09-30 was $94.46M.
- PACIRA BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2018 was $20.58M.
- PACIRA BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$223.76M.
- PACIRA BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$61.75M.
- PACIRA BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$19.26M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | -$181.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$103.32M 10-Q · filed 2019-08-08 | -$226.48M derived: sum of 3 quarters · filed 2019-08-08 | -$132.02M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2019-03-31 | $78.48M 10-Q · filed 2019-05-02 | -$44.68M derived: sum of 2 quarters · filed 2019-05-02 | $49.78M derived: sum of 3 quarters · filed 2019-05-02 | $109.35M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-12-31 | -$123.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$28.70M derived: sum of 2 quarters · filed 2019-02-28 | $30.87M derived: sum of 3 quarters · filed 2019-08-08 | $20.58M 10-K · filed 2019-02-28 | ||||
| 2018-09-30 | $94.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $154.03M derived: sum of 2 quarters · filed 2019-08-08 | $143.74M 10-Q · filed 2018-11-01 | $152.44M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-06-30 | $59.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $49.28M 10-Q · filed 2019-08-08 | $57.98M derived: sum of 3 quarters · filed 2019-08-08 | $30.50M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$10.29M 10-Q · filed 2019-05-02 | -$1.59M derived: sum of 2 quarters · filed 2019-05-02 | -$29.07M derived: sum of 3 quarters · filed 2019-05-02 | -$90.22M derived: sum of 4 quarters · filed 2019-05-02 | ||||
| 2017-12-31 | $8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$18.78M derived: sum of 2 quarters · filed 2019-02-28 | -$79.93M derived: sum of 3 quarters · filed 2019-02-28 | -$223.76M 10-K · filed 2019-02-28 | ||||
| 2017-09-30 | -$27.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$88.63M derived: sum of 2 quarters · filed 2018-11-01 | -$232.46M 10-Q · filed 2018-11-01 | -$239.38M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | -$61.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$204.99M 10-Q · filed 2018-08-02 | -$211.90M derived: sum of 3 quarters · filed 2019-02-28 | -$225.22M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | -$143.84M 10-Q · filed 2018-05-03 | -$150.75M derived: sum of 2 quarters · filed 2019-02-28 | -$164.07M derived: sum of 3 quarters · filed 2019-02-28 | -$183.72M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | -$6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$20.24M derived: sum of 2 quarters · filed 2019-02-28 | -$39.88M derived: sum of 3 quarters · filed 2019-02-28 | -$61.75M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | -$13.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$32.96M derived: sum of 2 quarters · filed 2017-11-08 | -$54.84M 10-Q · filed 2017-11-08 | -$47.54M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-06-30 | -$19.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$41.52M 10-Q · filed 2017-08-02 | -$34.22M derived: sum of 3 quarters · filed 2018-02-28 | -$42.96M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | -$21.88M 10-Q · filed 2017-05-04 | -$14.58M derived: sum of 2 quarters · filed 2018-02-28 | -$23.32M derived: sum of 3 quarters · filed 2018-02-28 | -$41.33M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2015-12-31 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$1.45M derived: sum of 2 quarters · filed 2018-02-28 | -$19.46M derived: sum of 3 quarters · filed 2018-02-28 | -$19.26M 10-K · filed 2018-02-28 | -$20.23M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | -$8.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$26.75M derived: sum of 2 quarters · filed 2016-11-02 | -$26.55M 10-Q · filed 2016-11-02 | -$27.49M 10-Q · filed 2015-10-27 | -$146.99M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | -$18.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$17.81M 10-Q · filed 2016-08-04 | -$20.65M 10-Q · filed 2015-07-30 | -$138.24M derived: sum of 3 quarters · filed 2017-03-01 | -$239.43M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $200.00K 10-Q · filed 2016-05-02 | -$1.16M 10-Q · filed 2015-04-30 | -$120.23M derived: sum of 2 quarters · filed 2017-03-01 | -$221.42M derived: sum of 3 quarters · filed 2017-03-01 | -$251.99M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | -$120.43M 10-K · filed 2017-03-01 | -$221.62M derived: sum of 2 quarters · filed 2017-03-01 | -$252.19M derived: sum of 3 quarters · filed 2017-03-01 | -$120.43M 10-K · filed 2016-02-25 | -$119.34M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | -$101.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | -$131.76M derived: sum of 2 quarters · filed 2015-10-27 | -$122.74M 10-Q · filed 2015-10-27 | -$123.36M 10-Q · filed 2014-10-30 | -$107.52M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-06-30 | -$30.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$21.55M 10-Q · filed 2015-07-30 | -$6.33M derived: sum of 3 quarters · filed 2016-02-25 | -$2.72M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $9.02M 10-Q · filed 2015-04-30 | $24.24M derived: sum of 2 quarters · filed 2016-02-25 | $27.86M derived: sum of 3 quarters · filed 2016-02-25 | $22.33M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $15.22M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $18.84M derived: sum of 2 quarters · filed 2016-02-25 | $13.31M derived: sum of 3 quarters · filed 2016-02-25 | -$42.94M 10-K · filed 2016-02-25 | -$43.56M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$1.91M derived: sum of 2 quarters · filed 2014-10-30 | -$58.16M 10-Q · filed 2014-10-30 | -$35.80M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | -$5.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$61.77M 10-Q · filed 2014-07-31 | -$39.41M derived: sum of 3 quarters · filed 2015-02-24 | -$41.22M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | -$56.25M 10-Q · filed 2014-05-01 | -$33.89M derived: sum of 2 quarters · filed 2015-02-24 | -$35.70M derived: sum of 3 quarters · filed 2015-02-24 | -$83.24M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $22.36M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $20.55M derived: sum of 2 quarters · filed 2015-02-24 | -$26.99M derived: sum of 3 quarters · filed 2015-02-24 | -$29.52M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | -$1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | -$49.35M derived: sum of 2 quarters · filed 2013-10-31 | -$51.88M 10-Q · filed 2013-10-31 | -$63.65M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | -$47.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$50.07M 10-Q · filed 2013-08-06 | -$61.84M derived: sum of 3 quarters · filed 2014-02-25 | -$64.41M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | -$2.53M 10-Q · filed 2013-05-08 | -$14.30M derived: sum of 2 quarters · filed 2014-02-25 | -$16.86M derived: sum of 3 quarters · filed 2014-02-25 | -$37.82M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | -$11.77M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$14.33M derived: sum of 2 quarters · filed 2014-02-25 | -$35.29M derived: sum of 3 quarters · filed 2014-02-25 | -$36.12M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | -$2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$23.52M derived: sum of 2 quarters · filed 2012-11-01 | -$24.36M 10-Q · filed 2012-11-01 | -$27.30M derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2011-06-30 | -$20.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$21.79M 10-Q · filed 2012-08-09 | -$24.74M derived: sum of 3 quarters · filed 2013-03-07 | |||||
| 2011-03-31 | -$832.00K 10-Q · filed 2012-05-09 | -$3.78M derived: sum of 2 quarters · filed 2013-03-07 | ||||||
| 2010-12-31 | -$2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$6.77M 10-K · filed 2013-03-07 | ||||||
| 2010-09-30 | -$3.82M 10-Q · filed 2011-10-31 | |||||||
| 2009-12-31 | -$5.51M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |